Literature DB >> 20579532

Kidney transplant function using organs from non-heart-beating donors maintained by mechanical chest compressions.

Alonso Mateos-Rodríguez1, Luis Pardillos-Ferrer, José María Navalpotro-Pascual, Carlos Barba-Alonso, María Eugenia Martin-Maldonado, Amado Andrés-Belmonte.   

Abstract

OBJECTIVE: This study aims to determine the failure rate of transplanted kidney grafts in recipients of organs from non-heart beating donors (NHBDs) who have had mechanical chest compressions to maintain a circulation before organ retrieval.
METHODS: A retrospective observational study based on review of the emergency medical service database and case histories of NHBDs, and information periodically sent by transplant units about donors and organs. The following variables were studied: age, sex, transfer hospital, time to arrival on the scene of cardiopulmonary arrest, time to arrival in hospital, number and type of organs retrieved, use of mechanical chest compression devices, and kidney function in graft recipients. The study covered the period between January 2008 and November 2009. During 2008 standard manual chest compressions were used and during 2009 mechanical chest compression devices were used.
RESULTS: In 39 transplanted kidneys from donors receiving mechanical chest compressions primary failure was documented in recipients on two occasions (5.1%). Kidneys transplanted from donors who had manual chest compressions resulted in three primary failures in recipients (9.1%). The difference between the two groups was not significant (p=0.5). Three patients achieved successful return of spontaneous circulation in the mechanical chest compression group after initiation of the NHBD donor protocol.
CONCLUSION: We have described our experience and protocol for non-heart beating donation using victims of out-of-hospital cardiac arrest in whom cardiopulmonary resuscitation has been unsuccessful as donors. Primary kidney graft failure rates in organs from non-heart beating donors is similar when manual or mechanical chest compression devices are used during cardiopulmonary resuscitation.

Entities:  

Mesh:

Year:  2010        PMID: 20579532     DOI: 10.1016/j.resuscitation.2010.04.024

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  8 in total

1.  Traumatic injuries after mechanical cardiopulmonary resuscitation (LUCAS2): a forensic autopsy study.

Authors:  Christelle Lardi; Coraline Egger; Robert Larribau; Marc Niquille; Patrice Mangin; Tony Fracasso
Journal:  Int J Legal Med       Date:  2015-01-27       Impact factor: 2.686

Review 2.  Kidney donation after cardiac death.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-06-06

Review 3.  ICU Management of the Potential Organ Donor: State of the Art.

Authors:  Carolina B Maciel; David M Greer
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

4.  Protocols for uncontrolled donation after circulatory death: a systematic review of international guidelines, practices and transplant outcomes.

Authors:  Iván Ortega-Deballon; Laura Hornby; Sam D Shemie
Journal:  Crit Care       Date:  2015-06-24       Impact factor: 9.097

5.  Donation after brain circulation determination of death.

Authors:  Anne L Dalle Ave; James L Bernat
Journal:  BMC Med Ethics       Date:  2017-02-23       Impact factor: 2.652

6.  Circulatory Arrest, Brain Arrest and Death Determination.

Authors:  Sam David Shemie; Dale Gardiner
Journal:  Front Cardiovasc Med       Date:  2018-03-13

Review 7.  Mechanical CPR: Who? When? How?

Authors:  Kurtis Poole; Keith Couper; Michael A Smyth; Joyce Yeung; Gavin D Perkins
Journal:  Crit Care       Date:  2018-05-29       Impact factor: 9.097

Review 8.  [Adult advanced life support].

Authors:  Jasmeet Soar; Bernd W Böttiger; Pierre Carli; Keith Couper; Charles D Deakin; Therese Djärv; Carsten Lott; Theresa Olasveengen; Peter Paal; Tommaso Pellis; Gavin D Perkins; Claudio Sandroni; Jerry P Nolan
Journal:  Notf Rett Med       Date:  2021-06-08       Impact factor: 0.826

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.